Standard Lithium Ltd vs 22nd Century Group Inc — how do they compare? Standard Lithium Ltd trades at $1.58 (market cap $398.07M), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Standard Lithium Ltd is far larger — about 640.3× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 1,564,155). Which is the better fit depends on your goals — on Pluang, investors hold Standard Lithium Ltd for 23 Days and 22nd Century Group Inc for 32 Days on average.
| SLI | XXII | |
|---|---|---|
Market Cap | $398.07M | $621.67K |
Volume | 1,564,155 | 45,625 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $5.65 | $483.00 |
52-Week Low | $1.61 | $0.80 |
Typical Hold Time | 23 Days | 32 Days |
Enterprise Value | $260.98M | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Standard Lithium (SLI) trades at $1.58, down 4.24% today, with a bearish technical signal but bullish oscillators. The company shows negative profitability metrics with ROE at -15.55% and net income of -$48.40M for 2025, though recent quarterly EPS have beaten expectations. Positive developments include progress toward a final investment decision for the South West Arkansas lithium project by end of 2026 and expanded offtake agreements.
The outlook is mixed: analyst consensus is strongly bullish with a $3.83 price target (142% upside), but execution risks remain high as the company transitions to production. Key risks include project delays, funding needs, and negative cash flow from operations. The stock offers high potential reward but requires careful risk assessment given pre-revenue status.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →